FRE.AX · FIREBRICK PHARMA LIMITED
Australia · RS rating 39 · As of 2026-10-14
| Price | 0.03 AUD |
|---|---|
| 1-day change | +3.5% |
| RS rating (overall / 1M / 3M / 12M) | 39 / 67 / 73 / 21 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 24 / 14 / 11 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +57.1% |
| Market cap (USD) | $5.8M |